期刊文献+

江苏省连云港市肺结核患者耐药状况分析 被引量:7

Analysis of drug susceptibility profiles of Mycobacterium tuberculosis in Lianyungang of Jiangsu province
下载PDF
导出
摘要 目的分析江苏省连云港市肺结核患者结核分枝杆菌耐药状况,为今后制定结核病预防控制策略提供依据。方法连续纳入2011年1—9月连云港市各区(县)疾病预防控制中心或结核病定点医院确诊的痰涂片阳性肺结核患者522例,其中初治患者396例,复治患者126例。连云港市第四人民医院实验室采用简单法对所有纳入的522例肺结核患者标本进行结核分枝杆菌固体培养和比例法药物敏感性试验。结果培养阳性的479株结核分枝杆菌中,任意耐药的菌株为151株(31.5%),其中初治患者和复治患者任意耐药率分别为20.9%(76/363)和64.7%(75/116),复治患者任意耐药率显著高于初治患者(χ2=77.84,P<0.001)。此外,初治患者中单耐药率(11.6%,42/363)与复治患者(11.2%,13/116)相近,两者差异无统计学意义(χ2=0.011,P=1.000);而复治患者耐2种药物(18.1%,21/116)、3种药物(17.2%,20/116)及3种药物以上(18.1%,21/116)的率均显著高于初治患者[分别为3.6%(13/363)、1.7%(6/363)、4.1%(15/363)](χ2值分别为28.11、41.61和24.69,P值均小于0.001)。结论江苏省连云港市涂阳肺结核患者耐药疫情比较严重,复治患者为主要耐药人群。 Objective To investigate the prevalence of drug-resistant tuberculosis (TB) in Lianyungang and provide the evidence for strategy development of TB control and prevention. Methods Five hundred and twenty-two smear positive pulmonary TB patients registered from January to September 2011 in the counties were consecutively enrolled, among whom 396 new cases and 126 re-treat cases. Solid culture method was used for sputum culture. The proportion method was used to detect the drug susceptibility of Mycobacterium tuberculosis (M. tuberculosis). Results Out of 479 isolates in the present study, there were 151 (31.5%) strains resistant to any anti-tuberculous drug. The drug resistant rates to any anti-TB drug among new and re-treated cases were 20.9% (76/363) and 64.7% (75/116), respectively, and the difference between the two groups was significant (χ2=77.84, P〈0.001). In addition, the drug resistant rates to single drug were similar among new (11.6%,42/363) and re-treated cases (11.2%,13/116) (χ2=0.011,P=1.000), while there were more strains resistant to two drugs (18.1%, 21/116), three drugs(17.2%, 20/116) and more than three drugs(18.1%, 21/116) in the re-treated group than new group (χ2=28.11,41.61,24.69;all P〈0.001). Conclusion The epidemic situation of smear-positive pulmonary tuberculosis patients with drug resistance is serious, and re-treated patients are the main population with drug resistance.
出处 《中国防痨杂志》 CAS 2013年第12期969-972,共4页 Chinese Journal of Antituberculosis
基金 中国卫生部-比尔及梅琳达.盖茨基金会结核病防治项目(2009-04-01)
关键词 结核 分枝杆菌 结核 抗药性 细菌 连云港市 Tuberculosis, pulmonary Mycobacterium tuberculosis Drug resistance, bacterial Lianyungang city
  • 相关文献

参考文献12

二级参考文献49

  • 1赵大海,徐飚.结核病与贫穷[J].中国防痨杂志,2004,26(3):177-179. 被引量:42
  • 2Nachega JB, Chaisson RE. Tuberculosis drug resistance : a global threat [J]. Clin Infect Dis, 2003, 36(Suppl 1) : S24 -30. 被引量:1
  • 3中华人民共和国卫生部.全国结核病耐药性基线调查报告(2007-2008年)[M].北京:人民卫生出版社,2010:25-52. 被引量:36
  • 4中华人民共和国卫生部.全国结核病耐药性基线调查报告(2007-2008年).北京:人民卫生出版社,2010:1-8. 被引量:27
  • 5WHO. Global Tuberculosis Control: epidemiology, strategy, financing. WHO report 2009 [R]. World Health Organization, 2009. http://www. who.int/tb/publieations/global_report/2009/en/index.html. 被引量:1
  • 6Doustdar F, Khosravi AD, Farnia P, et al. Molecular analysis of isoniazid resistance in different genotypes of Mycobacterium tuberculosis isolates from Iran[J]. Microb Drug Resist, 2008, 14: 273-279. 被引量:1
  • 7Wright A, Zignol M, Van-Deun A, et al. Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Sureillance [J]. Lancet, 2009, 373: 1861-1873. 被引量:1
  • 8王海艳,刘中学,石新华,刘虹,赵林立.牛结核病的现状与未来研究方向[J].检验检疫科学,2007,17(3):63-66. 被引量:16
  • 9中国防痨协会基础专业委员会.结核病诊断实验室检验规程[M].北京:中国教育出版社,2006.13-16. 被引量:232
  • 10Zhao Y, Xu S, Wang L, et al. National survey of drug resist-ant tuberculosis in China. N Engl J Med, 2012, 366 (23): 2161- 2170. 被引量:1

共引文献223

同被引文献47

  • 1殷素素,何钟宓.抗结核药物致肝损害116例临床分析[J].华西医学,2008,23(5):1065-1067. 被引量:11
  • 2郭虹,李环,李淑芬,王淑玲.抗结核药物治疗对肝功能的影响[J].北华大学学报(自然科学版),2005,6(5):425-427. 被引量:14
  • 3王甦民,刘宇红,姜广路,刘洋,付育红,端木宏谨.世界卫生组织中国结核病耐药监测的结果评价[J].中华检验医学杂志,2007,30(8):863-866. 被引量:48
  • 4赵辉.中国结核病防治规划实施工作指南(2008年版)对门诊医生的要求//2011年山东防痨协会学术年会论文汇编[C].2011年I山东防痨讲会学术年会,2011:30-32. 被引量:2
  • 5Devarbhavi H, Dierkhising R, Kremers WK, et al. Single-center experi- ence with drug-induced liver injury from India: causes, outcome, prog- nosis, and predictors of mortality[J]. Am J Gastroenterol,2010,105(11): 2396-404. (PMID:20648003). 被引量:1
  • 6Shakya R, Rao BS, Shrestha B. Incidence of hepatotoxieity due to anti- tubercular medicines and assessment of risk factors[J]. Ann Pharmaco- ther,201M,38(6): 1074-9. (PMID:I512201M). 被引量:1
  • 7Wong WM, Wu PC, Yuen MF, et al. Antituberculosis drug-related liv- er dysfunction in chronic hepatitis B infection[J]. Hepatology,2000, 31 (1): 201-6. (PMID:I0613746). 被引量:1
  • 8Hunt CM, Westerkam WR, Stave GM. Effect of age and gender on the activity of human hepatic CYP3A[J]. Biochem Pharmacol,1992, 44(2): 275-83. (PMID: 1642641). 被引量:1
  • 9Saukkonen JJ, Cohn DL, Jasmer RM, et al. An official ATS statement: hepatotoxicity of anfitubereulosis therapy[J]. Am J Respir Crit Care Med,2006,174(8): 935-52. (PMID: 17021358). 被引量:1
  • 10杨慧媛,宋育林,许建明.抗结核药物肝毒性研究现状及其存在的问题[J].安徽医药,2008,12(4):289-292. 被引量:20

引证文献7

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部